Research

Research

Ultraviolet Blood Irradiation (UBI), also referred to as Light Blood Irradiation (LBI), has been administered to treat various conditions for decades. Even though UBI has been widely used, it has not been adopted as a standard of care. This can be explained by two primary reasons: no robust clinical studies and no Food and Drug Administration approval. Although general adoption remains elusive, robust claims have been made concerning the utility of UBI.   Click on a condition below to review a summary of published clinical literature.

Studied Applications

Iritis: Subacute iritis with or without iridocyclitis
Chronic Osteomyelitis
Severe Pneumonia (Infants and Children)
Bacterial Infections
Tuberculosis
Sinusitis/Highmoritis
Irido-Cyclitis, Uveitis, Retro-bulbar neuritis, Herpes zoaster opthmalmicus, keratitis
Hepatitis
Human Immunodeficiency Virus (HIV)
Out of all 50 patients all UBI patients recovered without complications. In the control group receiving corticosteroids 20% became blind in the affected eye, there were several complications and they more slowly. (Miley, Ultraviolet Blood Irradiation…33 ). Typhoid Fever More effective when used as monotherapy as opposed to that in combination with sulfa drugs. (Rebback and Lewis, 640-649) Streptococcal infections Strep Infections has been successfully treated. Strep throat, rheumatic fever, scarlet fever, acute tonsillitis, acute otitis media and erysipelas all are very responsive to UBI treatment. (Miley, Olney and Lewis ‘Ultraviolet Blood Irradiation: A History’ ) Staphylococcus aureus for those using just UBI just as a treatment 8 out of 9 ended in complete recovery. The one case also had bladder carcinoma. Conclusion that UBI as a monotherapy was highly effective against staphylococcemia (Miley, ‘ Eficacy Ultraviolet Blood…’ 313-322)

Commitments

Although a few studies have assessed the clinical utility of UBI for the aforementioned conditions, these claims remain largely unsubstantiated. It is encouraging that an application may play such a diverse role in medicine, but UVLrx Therapeutics™ is dedicated to separating FACT from FICTION. Each of the aforementioned claims requires the completion of a well-designed clinical study with independent review board approval.  This is a daunting and time-consuming endeavor, but it is an endeavor that UVLrx Therapeutics™ is proud to pursue!

Connect Now

Your Name (required)

Your Phone number (required)

Your Email (required)

Your Name (required)

Your Email (required)

Your Phone

Subject

Your Message